| Dr Richard Josph Loewenstein, MD | |
|
6501 N Charles St, Baltimore, MD 21204-6819 | |
| (410) 938-5075 | |
| (410) 938-5072 |
| Full Name | Dr Richard Josph Loewenstein |
|---|---|
| Gender | Male |
| Speciality | Psychiatry & Neurology - Psychiatry |
| Location | 6501 N Charles St, Baltimore, Maryland |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1013092873 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2084P0800X | Psychiatry & Neurology - Psychiatry | D0025986 (Maryland) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Richard Josph Loewenstein, MD 6501 N Charles St, Baltimore, MD 21204-6819 Ph: (410) 938-5075 | Dr Richard Josph Loewenstein, MD 6501 N Charles St, Baltimore, MD 21204-6819 Ph: (410) 938-5075 |
News Archive
University of Louisville bioengineering researchers will use a $3.33 million award from the Wallace H. Coulter Foundation to help commercialize promising academic innovations into medical solutions to benefit patients.
Jackson Laboratory researchers have demonstrated that a single, targeted x-ray treatment of an individual eye in young, glaucoma-prone mice provided that eye with apparently life-long and typically complete protection from glaucoma.
Iron deficiency in the first four weeks of a piglet's life - equivalent to roughly four months in a human infant - impairs the development of key brain structures, scientists report. The abnormalities remain even after weeks of iron supplementation begun later in life, the researchers found.
Epigenetic changes occur in the DNA of breast cancer cells that have developed a resistance to hormone therapy, an effective treatment for ER+ breast cancer, which accounts for 70% of all diagnoses.
The National Institute on Aging (NIA), part of the National Institutes of Health, has awarded a $5 million grant to researchers at University of California San Diego School of Medicine to conduct a first-in-human Phase 1 clinical trial of a gene therapy for treating Alzheimer's disease (AD) or Mild Cognitive Impairment (MCI), a condition that often precedes full-blown dementia.
› Verified 1 days ago
Dr. Michelle Schnabel Horner, D.O. Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 5500 E Lombard St, Baltimore, MD 21224 Phone: 410-550-0091 | |
Dr. Priscilla Waldo Sheldon, M.D., PH.D. Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 1001 W Pratt St, Baltimore, MD 21223 Phone: 410-962-7180 Fax: 410-962-7194 | |
Haopeng Zheng, MD Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 345 Saint Paul Pl, Baltimore, MD 21202 Phone: 410-332-9000 | |
Ms. Sarah Catherine Collica, Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 600 North Wolfe St, Baltimore, MD 21287 Phone: 410-955-5000 | |
Abdullah Bin Zahid, MD Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 600 N Wolfe Street Phipps 455, Baltimore, MD 21264 Phone: 410-933-6423 | |
Chelsea Cosner, Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 701 W Pratt St Rm 474, Baltimore, MD 21201 Phone: 410-328-6325 | |
Michael Andre Torres, M.D. Psychiatry & Neurology Medicare: May Accept Medicare Assignments Practice Location: 600 Wyndhurst Ave, Suite 160, Baltimore, MD 21210 Phone: 410-617-0605 Fax: 443-773-1406 |